International Journal of Cancer Management

Published by: Kowsar

A Comparison of 5-HT3 Receptor Antagonist and Metoclopramide in the Patients Receiving Chemotherapeutic Regimens Including CMF, CAF and CHOP

Kazem Anvari 1 , Mehdi Seilanian-Toussi 1 , Hossein Hosseinzad-Ashkiki 2 and Soodabeh Shahidsales 1 , *
Authors Information
1 Cancer Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
2 Dept. of Radiation Oncology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
Article information
  • International Journal of Cancer Management: April 30, 2015, 8 (2); e80594
  • Published Online: April 30, 2015
  • Article Type: Research Article
  • Received: July 14, 2014
  • Accepted: January 07, 2015

To Cite: Anvari K, Seilanian-Toussi M, Hosseinzad-Ashkiki H, Shahidsales S. A Comparison of 5-HT3 Receptor Antagonist and Metoclopramide in the Patients Receiving Chemotherapeutic Regimens Including CMF, CAF and CHOP, Int J Cancer Manag. 2015 ; 8(2):e80594.

Abstract
© 2015, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Fulltext
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments